Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice.


Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 24 05 2019
revised: 22 03 2020
accepted: 27 03 2020
entrez: 21 6 2020
pubmed: 21 6 2020
medline: 8 7 2021
Statut: ppublish

Résumé

The objective of this study was to evaluate radiolabeled DOTA-SP90 as a radiotracer for breast cancer. The in vitro competition assay showed that radiolabeled DOTA-SP90 had significant binding affinity to BT-483 cancer cells. Biodistribution, nanoSPECT/CT and nanoPET/CT imaging results indicated that radiolabeled DOTA-SP90 can accumulate in tumors. In addition, radiolabeled DOTA-SP90 peptides can also detect metastatic tumors. Therefore, radiolabeled SP90 peptide may provide the potential capability as diagnostic agent for breast cancer patients.

Identifiants

pubmed: 32561130
pii: S0969-8043(20)30291-8
doi: 10.1016/j.apradiso.2020.109162
pii:
doi:

Substances chimiques

Gallium Radioisotopes 0
Heterocyclic Compounds, 1-Ring 0
Indium Radioisotopes 0
Oligopeptides 0
Radiopharmaceuticals 0
SP90 peptide 0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 1HTE449DGZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109162

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No competing financial interests exist.

Auteurs

Wei-Lin Lo (WL)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Chen-Hsien Liang (CH)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Liang-Cheng Chen (LC)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Shih-Ying Lee (SY)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Sheng-Nan Lo (SN)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Ming-Wei Chen (MW)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.

Ruei-Min Lu (RM)

Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.

I-Ju Liu (IJ)

Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.

Han-Chung Wu (HC)

Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.

Chih-Hsien Chang (CH)

Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan. Electronic address: chchang@iner.gov.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH